Quest PharmaTech’s Subsidiary
Home  »  Community News  »  Quest PharmaTech’s Subsidiary
Mar
23
ragupathyrenganathan
Quest PharmaTech’s Subsidiary, OncoQuest, Signs Agreement with Shenzhen Hepalink Pharmaceutical Co., Ltd. to Fund Immunotherapy for Treatment of Cancer in China
Pharma News
0
, , ,